Oral tenofovir discontinued in HIV clinical trial

Links shared publicly online about this topic.

0
total visits

Oral tenofovir discontinued in HIV clinical trial

A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that one of the study products, oral tenofovir, marketed under the trade name Viread, is effective.

View full resource at news-medical.net

Tags: HIV, AIDS, HIV Medication, STD, Drug, Clinical Trial, Viread, News

Most Recently Shared on September 29, 2011 at 2:20 pm By:

News-Medical.Net

HIV/AIDS News: Oral tenofovir discontinued in HIV clinical trial: A large-scale clinical trial evaluating whethe... http://t.co/uQ64lH9y

8 months ago...

Retweet

Favorite

AIDSmeds - Top Stories : Tenofovir Microbicide Gel Falters in Major HIV Prevention Study

aidsmeds.com — “HIV prevention efforts have suffered a major setback following a Microbicide Trials Network (MTN) announcement that a vaginal gel containing the antiretroviral tenofovir has been dropped from a large ongoing clinical trial because of lackluster effectiveness. The decision to discontinue the microbicide in the Vaginal and Oral Interventions to Control the Epidemic (VOICE) study was unexpected and contradicts the optimistic results of an earlier study of the same tenofovir-based gel.” View full resource at aidsmeds.com

Most Recently Shared on November 28, 2011 at 5:25 pm By:

AIDSmeds Health News

Top Stories : Tenofovir Microbicide Gel Falters in Major #HIV Prevention Study http://t.co/jokD5p2g #CAPRISA #VOICES #AIDS

6 months ago...

Retweet

Favorite

Medical News: Trial Shows Drugs Prevent HIV Before Exposure - in Clinical Context, HIV/AIDS from MedPage Today

medpagetoday.com — “Taking an anti-HIV pill every day can help prevent infection with the virus, researchers reported.” View full resource at medpagetoday.com